News & Articles
Selected Filters:
Pacific Biosciences and Invitae to develop whole genome sequencing-based assays for pediatric epilepsy diagnostics
The collaboration will focus on the investigation of clinically relevant molecular targets for use in the development of advanced diagnostic testing for epilepsy
New CRISPR-Based Products to Accelerate Disease Research
Agilent expands SureGuide portfolio with new CRISPR-based transcriptional activation and interference (a/i) libraries
QIAGEN Partners with World’s Largest Sequencing Provider
BGI will offer QIAGEN’s Ingenuity® Variant Analysis to 10,000-plus customers, beginning in China and expanding worldwide, for seamless interpretation of sequencing data
Webinar about Sequence Capture for NGS
What's Hot in CRISPR Gene Editing Technology
From CRISPR screening to CRISPR/Cas9-edited fusion proteins, we discover the latest technology, news and products in gene editing technology
Artel at ACMG
New Agreements Underscore QIAGEN’s Leadership in Bioinformatics
FDA centers and researchers gain access to QIAGEN’s enhanced solutions for applications including microbial and microbiome analysis
Point of care diagnostics: Heroes of the future
Uncover the remarkable evolution of point-of-care diagnostics as we examine the significant breakthroughs achieved over the years and explore exciting future directions
Agilent showcases comprehensive cancer portfolio solutions at AACR 2023
From cancer research to diagnostic solutions